Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis.

World J Psychiatry · 2019 · PMC6560499 · PMID 31211112

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Improvements were also noted in the UPDRS IV (complications of therapy) scores ( P = 0.06, effect size 0.55) in the pimavanserin group when compared to placebo but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.